Struggle with COPD?
Learn about a new phase 3 research study
for the potential treatment of COPD in adults
who smoke or have smoked.
Struggle with COPD?
Learn about a new phase 3 research study for the potential treatment of COPD in adults who smoke or have smoked.
Chronic obstructive pulmonary disease, or COPD, refers to a group of diseases that cause airflow blockage and breathing-related problems. It includes emphysema and chronic bronchitis.
COPD is the third leading cause of death by disease in the United States. More than 16.4 million people have been diagnosed with COPD, but millions more may have the disease without even knowing it.1
There is a phase 3 research study being conducted near you. Qualified participants will receive a triple-combination or dual-combination treatment and all required study-related care at no cost. Compensation for time and travel may be available.
You may qualify If you satisfy the criteria below:
- Current or ex-smoker
- Have had a documented COPD exacerbation within the past 12 months
- Be at least 40 years of age
There are additional criteria to participate. If you meet the above, fill out the pre-qualification form below and provide a research site location with your contact information.
About the Study
According to the CDC, this disease limits the daily lives of many. Some people cannot work or need special equipment like portable oxygen tanks. COPD leads to more emergency room visits and overnight hospital stays. It can cause depression and other mental or emotional conditions.2
The purpose of this study is to compare triple-combination treatment with a dual-combination treatment in improving lung function, reducing moderate and severe COPD exacerbations, and other clinical efficacy and safety outcomes in the target subject population.
The clinical research site will provide study participants that qualify with either a triple-combination treatment or a dual-combination treatment; it will be like a coin flip on what a qualified participant receives. Participants will attend regular visits to a local medical clinic at no cost. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects, and completing questionnaires. Eligible participants can be compensated for time and travel.
If you’re struggling with Chronic obstructive pulmonary disease, you may qualify for a new phase 3 research study, now being offered at select centers in multiple nations. This study will assess the effects of an investigational study drug in improving lung function and reducing COPD exacerbations. The effect of the treatment will be checked by medical assessments, checking for side effects, and completing questionnaires.
No-cost Study Care
You will receive study-related care from experienced doctors, nurses, and research staff.
The study will include blood, urine, and other examination visits with a trained investigator.
You might be eligible to receive compensation for your time and travel.